The Tempus AI, Inc. (NASDAQ: TEM) SEC filings page on Stock Titan provides access to the company’s official regulatory documents as filed with the U.S. Securities and Exchange Commission. Tempus is a healthcare technology company that applies artificial intelligence and multimodal data to precision medicine, and its filings offer insight into how it reports financial performance, manages capital, and documents material corporate events.
Investors can review Form 8-K filings where Tempus discloses items such as preliminary financial results, earnings press releases, credit agreement amendments, securities offerings, and other significant developments. For example, Tempus has used 8-K reports to furnish quarterly financial information, describe an automatic shelf registration statement and related prospectus supplement, and detail the terms of its convertible senior notes due 2030, including conversion features, redemption provisions, and associated capped call transactions.
Over time, this page will also surface Tempus’s annual reports on Form 10-K and quarterly reports on Form 10-Q, which typically include segment information for its Diagnostics and Data and applications businesses, risk factor discussions, and management’s analysis of operations. In addition, users can expect access to ownership and insider transaction disclosures, such as Form 4 filings, when they are available from EDGAR.
Stock Titan enhances these documents with AI-powered summaries that explain key points from lengthy filings in clear language. Real-time updates from EDGAR help ensure that new TEM filings appear promptly, while AI-generated highlights can draw attention to important terms in credit agreements, securities offerings, or covenant changes. This combination allows readers to navigate Tempus’s regulatory history more efficiently, from capital structure details to ongoing financial reporting.
Tempus AI, Inc. (TEM) reports that Chief Accounting Officer Ryan M. Bartolucci sold 7,062 shares of Class A Common Stock on September 17, 2026 at a price of $75.00 per share in an open-market or private transaction. After this sale, he holds 60,804 shares directly. The sale was made pursuant to a Rule 10b5-1 trading plan adopted on June 5, 2026.
Tempus AI, Inc. (TEM) reported that EVP and Chief Legal Officer Andrew Polovin sold 2,951 shares of Class A Common Stock on September 17, 2026 at $75.00 per share in an open market or private transaction. Following this sale, he directly holds 135,189 shares. The transaction was made pursuant to a Rule 10b5-1 trading plan adopted on August 12, 2025.
Tempus AI, Inc. (TEM) reported that executive officer Ryan Fukushima, CEO, Data, had an indirect sale of 700 shares of Class A Common Stock on September 16, 2026 at $70.00 per share, held through his spouse. This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by his spouse on March 12, 2026. Following the sale, indirect holdings by his spouse were 15,874 shares, and his direct holdings were 562,463 shares of Class A Common Stock.
Tempus AI, Inc. (TEM) is the issuer for a planned resale of its Class A Common Stock under Rule 144 on behalf of Eric Lefkofsky and affiliated entities. The notice covers up to 200,000 shares to be sold through J.P. Morgan Securities LLC, with an indicated aggregate market value of $13,994,000 and reference to 175,390,967 shares outstanding. The shares derive from prior direct investments in Tempus AI made in 2015, 2016 and 2020, and follow several recent Rule 144 sales by Blue Media, LLC, Gray Media, LLC, Lefkofsky Family Foundation and Vas.org Foundation during the prior three months.
Tempus AI, Inc. (TEM) has an affiliate filing a notice of proposed resale of common stock under Rule 144. Officer Ryan Bartolucci plans to sell 9,311 shares of Tempus AI common stock through Morgan Stanley Smith Barney, with an aggregate market value of $651,490.67 as of the filing details. The shares were acquired upon vesting of restricted stock units during the period from May 20, 2025 through November 17, 2025. Bartolucci previously sold 6,175 shares for $306,341.75 on August 18, 2026.
Tempus AI, Inc. (TEM) is the issuer for a Rule 144 notice filed by Andrew Polovin covering a proposed sale of 2,951 shares of common stock. These shares arise from Restricted Stock Units granted on May 20, 2025 and are to be sold through Morgan Stanley Smith Barney LLC on NASDAQ.
Over the prior three months, Polovin reported 10b5-1 sales of 7,927 common shares on August 19, 2026 with total proceeds of $443,912.00, providing context for the aggregation of sales under Rule 144.
Tempus AI, Inc. (TEM) has an officer, Vanessa Kubo, filing a notice of proposed sale of company stock under Rule 144. The filing covers the planned sale of 700 shares of common stock through Morgan Stanley Smith Barney LLC on or after September 16, 2026, with an aggregate market value of $48,195.00.
The shares to be sold were acquired as restricted stock awards from the issuer on October 14, 2015. The notice also lists prior sales in the past three months, including several 10b5-1 plan sales by Vanessa Kubo and a separate sale by Ryan Fukushima, which are disclosed for Rule 144 aggregation purposes.
Tempus AI, Inc. (TEM) reports that Fukushima Ryan, its CEO, Data, had an aggregate of 30,846 shares of Class A Common Stock sold on September 1, 2026 through accounts held by his spouse in open-market transactions under a Rule 10b5-1 trading plan adopted on March 12, 2026.
Following these indirect sales, he is reported as holding 562,463 shares of Class A Common Stock directly.
Tempus AI, Inc. (TEM) director Jennifer A. Doudna reported selling 676 shares of Class A common stock on September 1, 2026 at an average price of $65.55 per share. After this sale, she directly holds 25,266 shares. The sale was made under a Rule 10b5-1 trading plan adopted on August 12, 2025.
Tempus AI, Inc. (TEM) director David R. Epstein reported selling 250 shares of Class A Common Stock on September 1, 2026 at a price of $65.55 per share in an open-market or private transaction. After this sale, he directly holds 30,844 shares of Tempus AI Class A Common Stock.
The sale was carried out pursuant to a Rule 10b5-1 trading plan adopted by David R. Epstein on August 27, 2024, indicating the transaction followed a pre-arranged trading schedule.